(Q33178547)

23 July 2017

title

Synthesis and application of functionally diverse 2,6,9-trisubstituted purine libraries as CDK inhibitors (English)

1 reference

23 July 2017

Chang YT

1

1 reference

23 July 2017

Gray NS

2

1 reference

23 July 2017

Rosania GR

3

1 reference

23 July 2017

Sutherlin DP

4

1 reference

23 July 2017

Kwon S

5

1 reference

23 July 2017

Norman TC

6

1 reference

23 July 2017

Sarohia R

7

1 reference

23 July 2017

Leost M

8

1 reference

23 July 2017

Meijer L

9

1 reference

23 July 2017

Schultz PG

10

1 reference

23 July 2017

publication date

1 June 1999

1 reference

23 July 2017

published in

Chemistry and Biology

1 reference

23 July 2017

volume

6

1 reference

23 July 2017

issue

6

1 reference

23 July 2017

page(s)

361-375

1 reference

Inhibition of cyclin-dependent kinases by purine analogues.

23 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2899%2980048-9

7 January 2021

Biochemical and cellular effects of roscovitine, a potent and selective inhibitor of the cyclin-dependent kinases cdc2, cdk2 and cdk5.

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2899%2980048-9

7 January 2021

Multiple modes of ligand recognition: crystal structures of cyclin-dependent protein kinase 2 in complex with ATP and two inhibitors, olomoucine and isopentenyladenine

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2899%2980048-9

7 January 2021

Cyclin-dependent protein kinases: key regulators of the eukaryotic cell cycle

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2899%2980048-9

7 January 2021

Facile Preparation of 2,6-Disubstituted Purines Using Solid-Phase Chemistry

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2899%2980048-9

7 January 2021

Synthesis of C2 alkynylated purines, a new family of potent inhibitors of cyclin-dependent kinases

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2899%2980048-9

7 January 2021

Protein kinase inhibition by staurosporine revealed in details of the molecular interaction with CDK2

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2899%2980048-9

7 January 2021

Exploiting chemical libraries, structure, and genomics in the search for kinase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2899%2980048-9

7 January 2021

Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2899%2980048-9

7 January 2021

Cdk2 kinase is required for entry into mitosis as a positive regulator of Cdc2-cyclin B kinase activity

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2899%2980048-9

7 January 2021

The coordination of centrosome reproduction with nuclear events of the cell cycle in the sea urchin zygote

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2899%2980048-9

7 January 2021

The effect of the cyclin-dependent kinase inhibitor olomoucine on cell cycle kinetics

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2899%2980048-9

7 January 2021

Roscovitine, a novel cyclin-dependent kinase inhibitor, characterizes restriction point and G2/M transition in tobacco BY-2 cell suspension.

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2899%2980048-9

7 January 2021

10.1016/S1074-5521(99)80048-9

Identifiers

DOI

1 reference

23 July 2017

1 reference